Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Por Arab, Juan P., Karpen, Saul J., Dawson, Paul A., Arrese, Marco, Trauner, Michael
Publicado no Hepatology (2016)

Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus

Por Arab, Juan P, Claro, Juan C, Arancibia, Juan P, Contreras, Jorge, Gómez, Fernando, Muñoz, Cristian, Nazal, Leyla, Roessler, Eric, Wolff, Rodrigo, Arrese, Marco, Benítez, Carlos
Publicado no World J Hepatol (2016)

Aquaporin-1 Promotes Angiogenesis, Fibrosis, and Portal Hypertension Through Mechanisms Dependent on Osmotically Sensitive MicroRNAs

Por Huebert, Robert C., Jagavelu, Kumaravelu, Hendrickson, Helen I., Vasdev, Meher M., Arab, Juan P., Splinter, Patrick L., Trussoni, Christy E., LaRusso, Nicholas F., Shah, Vijay H.
Publicado em 2011

Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review

Por Arab, Juan P, Candia, Roberto, Zapata, Rodrigo, Muñoz, Cristián, Arancibia, Juan P, Poniachik, Jaime, Soza, Alejandro, Fuster, Francisco, Brahm, Javier, Sanhueza, Edgar, Contreras, Jorge, Cuellar, M Carolina, Arrese, Marco, Riquelme, Arnoldo
Publicado em 2014